These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
235 related articles for article (PubMed ID: 14984580)
1. The T1796A mutation of the BRAF gene is absent in Spitz nevi. Palmedo G; Hantschke M; Rütten A; Mentzel T; Hügel H; Flaig MJ; Yazdi AS; Sander CA; Kutzner H J Cutan Pathol; 2004 Mar; 31(3):266-70. PubMed ID: 14984580 [TBL] [Abstract][Full Text] [Related]
2. Analysis of mutations in B-RAF, N-RAS, and H-RAS genes in the differential diagnosis of Spitz nevus and spitzoid melanoma. van Dijk MC; Bernsen MR; Ruiter DJ Am J Surg Pathol; 2005 Sep; 29(9):1145-51. PubMed ID: 16096402 [TBL] [Abstract][Full Text] [Related]
3. BRAF and NRAS mutations in spitzoid melanocytic lesions. Fullen DR; Poynter JN; Lowe L; Su LD; Elder JT; Nair RP; Johnson TM; Gruber SB Mod Pathol; 2006 Oct; 19(10):1324-32. PubMed ID: 16799476 [TBL] [Abstract][Full Text] [Related]
4. Genetic similarities between Spitz nevus and Spitzoid melanoma in children. Gill M; Cohen J; Renwick N; Mones JM; Silvers DN; Celebi JT Cancer; 2004 Dec; 101(11):2636-40. PubMed ID: 15503312 [TBL] [Abstract][Full Text] [Related]
5. Mutations of the BRAF gene in benign and malignant melanocytic lesions. Yazdi AS; Palmedo G; Flaig MJ; Puchta U; Reckwerth A; Rütten A; Mentzel T; Hügel H; Hantschke M; Schmid-Wendtner MH; Kutzner H; Sander CA J Invest Dermatol; 2003 Nov; 121(5):1160-2. PubMed ID: 14708620 [TBL] [Abstract][Full Text] [Related]
7. Low prevalence of RAS-RAF-activating mutations in Spitz melanocytic nevi compared with other melanocytic lesions. Indsto JO; Kumar S; Wang L; Crotty KA; Arbuckle SM; Mann GJ J Cutan Pathol; 2007 Jun; 34(6):448-55. PubMed ID: 17518771 [TBL] [Abstract][Full Text] [Related]
8. Spitz melanoma is a distinct subset of spitzoid melanoma. Raghavan SS; Peternel S; Mully TW; North JP; Pincus LB; LeBoit PE; McCalmont TH; Bastian BC; Yeh I Mod Pathol; 2020 Jun; 33(6):1122-1134. PubMed ID: 31900433 [TBL] [Abstract][Full Text] [Related]
9. Oncogenic BRAF and the tumor suppressor IGFBP7 in the genesis of atypical spitzoid nevomelanocytic proliferations. Emley A; Yang S; Wajapeyee N; Green MR; Mahalingam M J Cutan Pathol; 2010 Mar; 37(3):344-9. PubMed ID: 19788444 [TBL] [Abstract][Full Text] [Related]
10. BRAF, NRAS and HRAS mutations in spitzoid tumours and their possible pathogenetic significance. Da Forno PD; Pringle JH; Fletcher A; Bamford M; Su L; Potter L; Saldanha G Br J Dermatol; 2009 Aug; 161(2):364-72. PubMed ID: 19438459 [TBL] [Abstract][Full Text] [Related]
11. Genomic aberrations in spitzoid melanocytic tumours and their implications for diagnosis, prognosis and therapy. Wiesner T; Kutzner H; Cerroni L; Mihm MC; Busam KJ; Murali R Pathology; 2016 Feb; 48(2):113-31. PubMed ID: 27020384 [TBL] [Abstract][Full Text] [Related]
12. Detection of the BRAF V600E mutation in melanocytic lesions using the ligase detection reaction. Turner DJ; Zirvi MA; Barany F; Elenitsas R; Seykora J J Cutan Pathol; 2005 May; 32(5):334-9. PubMed ID: 15811117 [TBL] [Abstract][Full Text] [Related]
13. BAP1 and BRAFV600E expression in benign and malignant melanocytic proliferations. Piris A; Mihm MC; Hoang MP Hum Pathol; 2015 Feb; 46(2):239-45. PubMed ID: 25479927 [TBL] [Abstract][Full Text] [Related]
14. p16 expression: a marker of differentiation between childhood malignant melanomas and Spitz nevi. Al Dhaybi R; Agoumi M; Gagné I; McCuaig C; Powell J; Kokta V J Am Acad Dermatol; 2011 Aug; 65(2):357-363. PubMed ID: 21550132 [TBL] [Abstract][Full Text] [Related]
15. Benign and Intermediate-grade Melanocytic Tumors With BRAF Mutations and Spitzoid Morphology: A Subset of Melanocytic Neoplasms Distinct From Melanoma. Zhao J; Benton S; Zhang B; Olivares S; Asadbeigi S; Busam K; Gerami P Am J Surg Pathol; 2022 Apr; 46(4):476-485. PubMed ID: 34753863 [TBL] [Abstract][Full Text] [Related]
16. Spitz nevi and Spitzoid melanomas: exome sequencing and comparison with conventional melanocytic nevi and melanomas. Lazova R; Pornputtapong N; Halaban R; Bosenberg M; Bai Y; Chai H; Krauthammer M Mod Pathol; 2017 May; 30(5):640-649. PubMed ID: 28186096 [TBL] [Abstract][Full Text] [Related]
17. Genetic and methylation profiles distinguish benign, malignant and spitzoid melanocytic tumors. Zaremba A; Jansen P; Murali R; Mayakonda A; Riedel A; Philip M; Rose C; Schaller J; Müller H; Kutzner H; Möller I; Stadtler N; Kretz J; Sucker A; Bankfalvi A; Livingstone E; Zimmer L; Horn S; Paschen A; Plass C; Schadendorf D; Hadaschik E; Lutsik P; Griewank K Int J Cancer; 2022 Nov; 151(9):1542-1554. PubMed ID: 35737508 [TBL] [Abstract][Full Text] [Related]
18. Loss of p16 expression and copy number changes of CDKN2A in a spectrum of spitzoid melanocytic lesions. Harms PW; Hocker TL; Zhao L; Chan MP; Andea AA; Wang M; Harms KL; Wang ML; Carskadon S; Palanisamy N; Fullen DR Hum Pathol; 2016 Dec; 58():152-160. PubMed ID: 27569296 [TBL] [Abstract][Full Text] [Related]
19. Lack of BRAF mutations in Spitz nevi. Gill M; Renwick N; Silvers DN; Celebi JT J Invest Dermatol; 2004 May; 122(5):1325-6. PubMed ID: 15140238 [No Abstract] [Full Text] [Related]
20. PRAME expression in melanocytic proliferations with intermediate histopathologic or spitzoid features. Raghavan SS; Wang JY; Kwok S; Rieger KE; Novoa RA; Brown RA J Cutan Pathol; 2020 Dec; 47(12):1123-1131. PubMed ID: 32700786 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]